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1. Introduction  
Colorectal cancer is the third most frequent cancer in the Western world. About half of the 
patients develop synchronous or metachronous metastases. The liver is the most common 
site of such metastases and thus hepatic metastatic disease is a significant socio-medical 
problem. If it is not treated, the median patient survival is only some months. Surgical 
resection is the treatment of choice for patients with isolated colorectal liver metastases 
when feasible. For patients with four or fewer isolated hepatic lesions, five year relapse-free 
survival rates range from 24 to 58 percent and ten year survival rates vary between 17 and 
33 percent. There is a convincing socio-epidemiological evidence of the dramatic 
unfavourable influence on population wealth of untimely diagnosis and inadequate 
treatment of the patients with advanced and metastatic colorectal cancer worldwide (Hata et 
al., 2010; Kostov & Kobakov, 2006a; Stillwell et al., 2011; Tsoulfas et al., 2011). 
2. Purposes of the study  
The purposes of the present paper are to define the variety of liver resections as an 
important component of the modern treatment of colorectal liver metastases, to describe 
their operative techniques and postoperative results, to illustrate some peculiar resection 
patterns from our own patients’ contingent and, based on our own experience with the 
complex preoperative diagnostic algorithm and the individualized indications and 
contraindications for surgery and multimodal therapy, to outline the advantages of different 
types of hepatic resections in properly selected cases with colorectal liver metastases as 
manifested by improved patient’s quality of life and survival.  
3. Material  
Patients’ contingent included a total of 158 patients who have undergone liver resections for 
colorectal liver metastases in the Department of Surgery, Naval Hospital of Varna and in the 
Division of Surgery, Marko Markov Interregional Dispensary and Hospital of Oncological 
Diseases of Varna, Bulgaria, during a 10-year period (January 1, 2000 - December 31, 2010). 
Results concerning 108 patients dynamically followed-up for at least one year after the 
operation were illustrated in this comprehensive retrospective study. Demographic 
characteristics, preoperative clinical, laboratory and functional diagnosis of the patients, 
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types of surgical interventions and conservative therapy as well as metastatic tumour 
localization, volume, number and staging were systematized. Only some of our data could 
be presented in the present paper. 
Number and mean age of male and female patients can be seen on Table 1. 
 
Gender 
Patients Mean age 
n % years range 
Males 68 63 58 36-81 
Females 40 37 54 32-79 
Total 108 100 59 32-81 
Table 1. Patients’ distribution according to gender and mean age 
4. Methods  
The algorithm for contemporary diagnostic evaluation comprised total colonoscopy, 
conventional chest radiography, conventional blood tests, serum levels of some tumour 
markers such as carcinoembryonic antigen (CEA), carbohydrate antigen CA 19.9 and 
carbohydrate antigen CA 242, abdominal preoperative and intraoperative ultrasonography 
(for estimation of the type and volume of liver resection), intraoperative cholangiography 
(for pre- and postoperative bile drainage evaluation in remnant hepatic parenchyma), 
methyene-blue injection through the portal vein (for assessment of afferent and efferent 
blood flow in remnant hepatic parenchyma), contrast-enhanced and spiral computed 
abdominal tomography, MRI in case of contradictory computer tomographic data and 
histopathology of enlarged hilar lymph nodes. The volume of the liver resection was 
determined not only by the number, size and localization of the metastases but also by the 
degree of compensatory hypertrophy of the intact hepatic volume. 
The presentation of all the types of surgical interventions included the following:  
i. types of surgical access, liver mobilization, hilar dissection, and hepatic-vein control,  
ii. operative approaches, and 
iii. operative volumes.  
Patients’ distribution according to the volume of liver resection is demonstrated on Table 2. 
During the last 8 years, a total of 14 patients underwent repeated liver resections. A third 
resection was done in three of these patients, and a fourth resection was done in two of these 
patients. 
Table 3 indicates the consecutive number and volume of primary and repeated liver 
resections. 
Some essential parameters of colorectal liver metastases in these repeated resections of 
different consecutive number are summarized on Table 4. 
Additionally, multimodal treatment of all the patients with colorectal liver metastases 
included a variety of chemotherapeutic protocols as aneoadjuvant and/or adjuvant 
chemotherapy along with radiofrequent ablation, portal vein embolization, and two-stage 
resection of bilobar colorectal liver metastases (Kostov & Kobakov, 2006). The effect of 
neoadjuvant chemotherapy was assessed according to the Response Evaluation Criteria in 
Solid Tumours (Eisenhauer et al., 2009). 
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Volume of resection Type of resection n=108 
Monosegmentectomy 
n=22 (20%) 
Sg1 3 
Sg2 2 
Sg3 3 
Sg4 5 
Sg5 2 
Sg6 3 
Sg7 2 
Sg8 2 
Bisegmentectomy 
n=24 (22%) 
Sg6,7 4 
Sg5,8 3 
Sg2,3 4 
Sg5,6 3 
Sg4b,5 2 
Sg1,4 2 
Sg7,8 2 
Sg4a,8 2 
Sg3,4b 1 
Sg4 + parts of Sg 1,2,3,5 1 
Multisegmentectomy 
n=62 (57%) 
Sg4,5,8 3 
Sg1,4,5,8 2 
Sg1,4b,5,6 1 
Sg5,6,7 1 
Sg3,5,6,7 1 
Sg3,4b,5 2 
Sg4 + part of Sg2,3 + metastasectomy of Sg8 1 
Sg4b,6,7 1 
Sg6,7,8 1 
Sg3+ parts of Sg4,6,8 1 
Left hemihepatectomy (Sg2,3,4±1) 13 
Right hemihepatectomy (Sg5,6,7,8±1) 32 
Right trisectionectomy (Sg1,4,5,6,7,8) 2 
Left trisectionectomy (Sg1,2,3,4,5,8) 1 
Table 2. Type and volume of liver resections 
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Number of 
resection 
Number of 
patients 
Volume of resection 
One Sg Two Sg Three Sg
Trisection-
ectomy 
Hemihepat-
ectomy 
Wedge 
resection 
First 14 2 6 2 2 2 - 
Second 14 - - - - - 14 
Third 3 - - - - - 3 
Fourth 2 - - - - - 2 
Table 3. Consecutive number and volume of resections 
 
Parameter First resection
Second 
resection 
Third resection
Fourth 
resection 
CEA > 200 ng/mL  9 9 3 2 
CEA ≤ 200 ng/mL 5 5 - - 
synchronous 5 - - - 
metachronous 9 14 3 2 
after < 12 months 6 - - - 
after ≥ 12 months 8 - - - 
    total number     
One 2 8 2 - 
two-three 7 6 1 - 
≥ three 5 - - 2 
unilobar 8 12 3 2 
bilobar 6 2 - - 
diameter < 20 mm 2 7 2 - 
diameter of 20-50 mm 8 5 1 1 
diameter ≥ 50 mm 4 1 - 1 
nodes in lig. hepato-
duodenale 
- - - 2 
positive margins - - - 2 
negative margins 14 14 3 - 
    MSKCC-CRS     
0-2 factors 8 8 1 - 
3-5 factors 6 6 2 2 
Table 4. Characteristics of colorectal liver metastases in repeated liver resections 
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One- and three-year survival data were retrospectively recorded up to December, 2010. 
Memorial Sloan-Kettering Cancer Center Clinical Risk Score (MSKCC-CRS) was used to 
evaluate the postoperative prognosis of the patients (Arru et al., 2008). 
Kaplan-Meier estimates outlined differences with Kaplan-Meier curves. Comparisons of sex 
and age between segmentectomy and major hepatectomy patients applied chi-square and t-
test. The t-test compared mean blood loss, diameter of colorectal liver metastases, duration 
of surgery, length of hospital stay, and resection margins. The postoperative complications 
were compared by means of Fisher’s exact test. Patients’ homogeneity was comparatively 
assessed by means of the log rank and Wilcoxon tests. 
5. Operative techniques of liver resections 
5.1 Types of surgical access  
The following types of surgical access for liver mobilization, hilar dissection, and hepatic-
vein control can be used (Kostov & Kobakov, 2010): 
Upper medial laparotomy with transversal enlargement to the right until 9th intercostal 
space along with Makuushi incision is most commonly performed to access right or left 
hemiliver while Mercedes-Benz incision is suitable to access both left and right hemilivers.  
Complete liver mobilization passes through five stages: i) interruption of lig. teres hepatis 
between two ligatures, ii) cutting of lig. falciforme hepatis up to the subdiaphragmatic part of 
vena cava inferior, iii) search for an accessory left hepatic artery as a branch of a. gastrica 
sinistra when cutting lig. hepatogastricum, iv) cutting to the left of both lig. triangularе 
sinistrum and lig. coronarium hepatis to left hepatic vein trunk and v) cutting to the right of 
both lig. triangularе dextrum and lig. coronarium hepatis to right hepatic vein trunk.  
Hilar dissection aims at dividing the vessels designed for the left and right hemiliver that 
enables the application of hemi-Pringle maneuver. Right hepatic vein extrahepatic part can 
be reached by interruption of Makuushi ligament. Right hepatic vein is lifted on rubber 
holder (Fig. 1).  
 
 
Fig. 1. Right hepatic vein mobilization and short retrohepatic veins 
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Usually, both left and middle hepatic veins present with a common trunk as their 
bifurcation is intraparenchymally located (Fig. 2).  
 
 
Fig. 2. Extrahepatic mobilization of three hepatic veins enables a complete vascular 
exclusion of the liver and preserves blood flow through vena cava inferior 
 
 
Fig. 3. Single ‘hаnging’-maneuver 
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Clamping the three hepatic veins enables a complete vascular exclusion with blood flow 
preservation through vena cava inferior. With single ‘hanging’-maneuver, a rubber tape 
passes cranially between the right and middle hepatic veins but caudally - between hilar 
vessels for the right and left hemiliver (Fig. 3).  
This method is applied in right/left hemihepatectomy or right segmentectomy. With double 
‘hanging’-maneuver, a second rubber tape is additionally used which passes cranially 
between the middle and left hepatic veins but caudally - between hilar vessels for the right 
and left hemiliver (Fig. 4). This method is applied in mesohepatectomy or proximal 
segmentectomy. With complete vascular exclusion and blood flow interruption through 
vena cava inferior the latter is clamped over the three hepatic veins and over the inflow of 
renal veins. For that purpose, vena cava inferior is mobilized at two sites - below the 
diaphragm and over the inflow of renal veins ( Fig. 5). Right suprarenal vein is obligatorily 
interrupted. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Double ‘hanging’-maneuver 
www.intechopen.com
 Colorectal Cancer – From Prevention to Patient Care 
 
416 
 
Fig. 5. Preparation for complete vascular exclusion and blood flow interruption through 
vena cava inferior. Cranial rubber tape passes circularly over the three hepatic veins but the 
caudal one does over renal veins. Right suprarenal vein is interrupted 
5.2 Operative approaches 
The following operative approaches can be made use of (Kostov & Kobakov, 2010): 
i. extrahepatic approach to the hepatic inflow pedicles for ligation of a portal triad to the 
Sg 1 and 4, right anterior section, right posterior section, left hemiliver and right 
hemiliver,  
ii. intrahepatic anterior approach to the hepatic inflow pedicles for ligation of a portal 
triad to an individual Sg (2, 3, 5, 6, 7 and 8),  
iii. intrahepatic posterior approach to the hepatic pedicles by using Glissonian sheaths, and  
iv. combined extrahepatic and intrahepatic approaches for ligation of a portal triad were 
used in some bisegmentectomies, right trisectionectomies, and left trisectionectomies. 
5.3 Operative volumes  
According to the localization and expansion of the pathologic process, one of the following 
operative volumes should be selected by liver surgeons (Kostov & Kobakov, 2010): 
5.3.1 Segmentectomies 
Stages of the following monosegmentectomies - segmentectomy 1 ( Sg 1), Sg 2, Sg 3, Sg 4, Sg 
5, Sg 6, Sg 7, Sg 8, and wedge resection:  
Segmentectomy 1 passes through five stages: i) devascularization of proc. caudatus, ii) 
devascularization of Spiegel’s lobe, iii) interruption of short retrohepatic veins which enter 
directly vena cava inferior, iv) mobilization of right, middle and left hepatic veins and v) 
parenchymal transection at the borderline between Sg1 and Sg4. Resection to the right ends 
at the borderline to Sg7. 
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The extrahepatic approach requires interruption of the afferent and efferent blood supply to 
the hepatic part outside the liver which is subject to removal. Among 
monosegmentectomies, only Sg1 devascularization can be entirely done through such an 
approach. With isolated segmentectomy 1, the line of parenchymal transsection passing 
behind the three hepatic veins is of interest (Fig. 6 through Fig. 8).  
 
 
Fig. 6. Line of parenchymal transsection (2) when removing Sg 1. Line of dividing the liver 
into left and right hemiliver (1); left (A), middle (B), and right veins (Liau et al., 2004) 
 
Fig. 7. Removed Sg1 - view from the left. LHV - left hepatic vein; MHV - middle hepatic 
vein; RHV- right hepatic vein 
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Fig. 8. Removed Sg1 - view from the right.  
Both segmentectomy 2 and segmentectomy 3 pass through three stages each: i) definition of 
borderlines of Sg2 and Sg3 ii) parenchymal transection with intraparenchymal interruption of 
portal triad vessels for Sg2 and Sg3 (Fig. 9) and iii) interruption of branches of left hepatic vein 
for Sg2 and Sg3 through anterior intrahepatic access (Fig. 10).  
 
 
 
Fig. 9. Sites for interruption of portal triad vessels for Sg2 and Sg3   
Segmentectomy 4 passes through five stages: i) extrahepatic interruption of the artery for 
lobus quadratus which, normally, is left hepatic artery branch, ii) ligation of some ascendent 
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portal veins through extrahepatic access, iii) interruption of descendent portal veins during 
parenchymal transection along lig. falciforme hepatis (Fig. 11), iv) opening and interruption of 
bile ducts for Sg4 in Rex recessus and v) parenchymal transection along Rex-Cantlie line as 
middle hepatic vein can be either interrupted, or preserved.  
 
 
Fig. 10. Anterior intrahepatic access to left hepatic vein 
 
 
Fig. 11. Ischaemic demarcation of Sg4  
Segmentectomy 5 passes through three stages: i) definition of resection borderlines of Sg5. 
Clamping the vessels for Sg5,8 causes their ischaemic demarcation and visualizes the left 
and right resection borderlines. The complete Sg5 volume is visualized after injection into 
segmental portal vein of 5 mL of methylene blue under echographic control, ii) parenchymal 
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transection along Rex-Cantlie line with intraparenchymal interruption of the vessels for Sg5 
and middle hepatic vein preservation. Sg5 devascularization induces ischaemic demarcation 
of its borderlines and iii) parenchymal transection at the borderline with Sg8 and Sg6. 
Resection line should pass over Ganz furrow in which the vessels for Sg6 are located.  
Segmentectomy 6 passes through three stages: i) definition of resection borderlines of Sg6. 
Clamping the artery and portal vein for Sg6,7 causes their ischaemic demarcation and 
visualizes the borderline to Sg5,8. The resection borderlines are visualized after injection into 
portal vein for Sg6,7 or into segmental portal vein for Sg6 of 5 mL of methylene blue under 
echographic control (Fig. 12). (ii) parenchymal transsection at the borderline between Sg5 and 
Sg6 with consecutive interruption of the vein and portal triad for Sg6. Sg6 ischaemia allows 
visualization of its borderline to Sg7 and iii) parenchymal transection along this bordeline.  
 
 
Fig. 12. Sg6 resection borderlines after metthylene-blue injection into segmental PV under 
echographic control  
Segmentectomy 7 passes through three stages: i) definition of resection borderlines of Sg7. 
Clamping the artery and portal vein for Sg6,7 causes their ischaemic demarcation and 
visualizes the borderline to Sg5,8. The resection borderlines are visualized after injection 
into portal vein for Sg6,7 or into segmental portal vein for Sg7 of 5 mL of methylene blue 
under echographic control. Right hepatic vein mobilization prevents bleeding during 
resection, (ii) parenchymal transection at the borderline between Sg7 and Sg8 with 
consecutive interruption of right hepatic vein right branch and portal triad vessels for Sg7. 
Sg7 ischaemic demarcation visualizes its borderline to Sg6 and iii) parenchymal transection 
along this borderline. 
Segmentectomy 8 can be performed through indirect and direct access. 
Indirect access - segmentectomy 8 passes through three stages: i) definition of resection 
borderlines of Sg8. Clamping the artery and vein for Sg5,8 causes their ischaemic 
demarcation. Right hepatic vein mobilization prevents bleeding during resection, (ii) 
parenchymal transection along Rex-Cantlie line with intraparenchymal interruption of the 
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vessels for Sg5 and middle hepatic vein preservation as portal triad vessels for Sg8 is 
caudally identified and interrupted. Parenchymal transection continues cranially to the 
borderline with middle hepatic vein where the vein for Sg8 is interrupted. Sg8 
devascularization visualizes its borderlines with Sg7 and Sg5 and iii) parenchymal 
transection along these bordelines in order to preserve right hepatic vein.  
Direct access consists in immediate intervention on Sg8. Parenchymal transection passes 
through three stages: i) definition of resection borderlines of Sg8 visualized after injection 
into PV for Sg8 of 5 mL of methylene blue under echographic control (Fig. 13). Clamping the 
artery and vein for Sg5,8 causes ischaemic demarcation of left and right resection 
borderlines. Right hepatic vein is clamped, if necessary, ii) parenchymal transection at the 
borderline between Sg4a and Sg8 as, caudally, the vein draining blood from Sg8 into middle 
hepatic vein and segmental portal triad vessels are consecutively interrupted. Sg8 
demarcation visualizes its borderlines with Sg5 and Sg7 and iii) parenchymal transection 
along these borderlines and obligatory preservation of right hepatic vein.  
Wedge resection consists in removal of some part of a given liver segment only. 
 
 
Fig. 13. Borderlines of Sg8 visualized after injection into PV for Sg8 of methylene blue under 
echographic control 
5.3.2 Bisegmentectomies 
Stages of the following bisegmentecomies - bisegmentectomy 2,3; 6,7; 5,8; 3,4b; 1,4; 4b,5; 5,6; 
7,8, and 4a,8:  
Bisegmentectomy 2,3 passes through three stages: i) mobilization of left hemiliver through 
consecutive interruption of lig. triangulare sinistrum and lig. coronarium hepatis sinistrum, ii) 
parenchymal transection along the left edge of lig. falciforme hepatis and caudal interruption 
of portal triad vessels for Sg2,3 and iii) left hepatic vein interruption either through 
extrahepatic access, or through anterior intrahepatic access at the end of parenchymal 
transection. 
Bisegmentectomy 6,7 passes through four stages: i) mobilization of right hemiliver through 
interruption of lig. triangulare dextrum and lig. coronarium hepatis dextrum. Extrahepatic 
www.intechopen.com
 Colorectal Cancer – From Prevention to Patient Care 
 
422 
portion of right hepatic vein is liberated and lifted on a rubber tape, ii) definition of 
resection borderline after interruption of the artery and portal vein for Sg6,7 or by injection 
of 5 mL of methylene blue into portal vein for Sg6,7, iii) parenchymal transection at the 
borderline between Sg6,7 and Sg5,8. Caudally, both the vein for Sg6 draining blood into 
right hepatic vein anterior branch and portal triad vessels for Sg6,7 under it are interrupted 
and iv) at the end of parenchymal transection, right hepatic vein posterior branch draining 
blood from Sg7 is interrupted as its anterior branch is preserved. 
Bisegmentectomy 5,8 passes through four stages: i) mobilization of right hemiliver through 
interruption of lig. triangulare dextrum and lig. coronarium hepatis dextrum. Extrahepatic 
portion of right hepatic vein is liberated and lifted on a rubber tape, ii) definition of 
resection borderlines of Sg5,8. Extrahepatic interruption of the artery (Fig. 14) and portal 
vein (Fig. 15) for Sg5,8 causes their ischaemic demarcation (Fig. 16). Sg 5,8 visualization after 
injection of 5 mL of methylene blue into portal vein for Sg5,8, iii) parenchymal transection at 
the borderline to lobus quadratus through consecutive interruption of the vein for Sg5 
draining blood into middle hepatic vein, of the portal triad vessels for Sg5,8 and the vein 
draining blood from Sg8 into middle hepatic vein. Sg5,8 devascularization results in 
ischaemic demarcation line at the borderline to Sg6,7 and iv) parenchymal transection along 
this borderline includes interruprion of the vein draining blood from Sg5 into right hepatic 
vein as both middle and right hepatic veins are obligatorily preserved. 
Bisegmentectomy 3,4b passes through three stages: i) definition of resection borderlines by 
means of intraoperative echography. To the left, parenchymal transection passes along left 
hepatic vein but to the right it does along Rex-Cantlie line. Both left and middle hepatic 
veins are preserved, ii) parenchymal transection along lig. falciforme hepatis reaching 
caudally to the vessels for left segments. Only portal triad vessels for Sg3 and bile ducts for 
Sg4b are interrupted. Sg3 ischaemia causes demarcation of its borderline to Sg2 along which 
parenchymal transection is performed and iii) parenchymal transection along Rex-Cantlie 
line at the borderline between Sg4b and Sg5. 
 
 
Fig. 14. Mobilization and preparation for interruption of the artery for Sg5,8. RHA - right 
hepatic artery 
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Fig. 15. Mobilization and preparation for interruption of portal vein for Sg5,8. RPV - right 
portal vein 
 
Fig. 16. Ischaemic demarcation of Sg5,8 after their devascularization 
Bisegmentectomy 1,4 passes through five stages: i) mobilization of left and right hemiliver 
and definition of Sg4 resection borderlines. To the left, parenchymal transection passes 
along lig. falciforme hepatis but to the right it follows middle hepatic vein course as defined 
by means of intraoperative echography, ii) Sg4 devascularization by consecutive 
interruption of the artery and ascendant portal veins for Sg4 through extrahepatic access, iii) 
parenchymal transection along lig. falciforme hepatis and, caudally, interruption of 
descendent portal veins for Sg4. After interruption of portal veins for lobus quadratus, Rex 
recessus is reached where the bile duct for Sg4 is identified and interrupted, iv) Sg1 
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devascularization through extrahepatic access and v) parenchymal transection along Rex-
Cantlie line. Cranially, middle hepatic vein is interrupted, if necessary. After 
bisegmentectomy 1,4, a large parenchymal defect is formed at which bottom the 
retrohepatic portion of vena cava inferior is visible. 
Bisegmentectomy 4b,5 passes through four stages: i) definition of resection borderlines. To 
the left, parenchymal transection passes along lig. falciforme hepatis but to the right it does 
along Rex-Cantlie line. Hilar dissection with division of vessels for right and left hemiliver 
enables selective clamping the artery and portal vein for Sg2-8, if necessary, ii) parenchymal 
transection along lig. falciforme hepatis as the artery for Sg4 is provisorily clamped as well as 
ascendant portal veins and bile duct for Sg4b are interrupted, iii) parenchymal transection in 
a transversal plane at the borderline between Sg4b and Sg5, on the one hand, and between 
Sg4a and Sg8, on the other hand. Resection line is defined by means of intraoperative 
echography. Consecutively, distal portion of middle hepatic vein and portal triad vessels for 
Sg5 are interrupted and iv) Sg5 ischaemia results in demarcation line at the borderline to 
Sg6 along which parenchymal transection is performed. Caudally, the vein draining blood 
from Sg5 into right hepatic vein anterior branch is interrupted and portal triad vessels for 
Sg6-8 are obligatorily preserved. 
Bisegmentectomy 5,6 passes through three stages: i) hilar dissection and isolation of the 
vessels for right hemiliver. Their clamping visualizes the parenchymal transection line 
between Sg5 and Sg6. Resection borderlines in bisegmentectomy 5,6 are defined by means of 
intraoperative echography, too, ii) parenchymal transection at the borderline between Sg4 
and Sg5 and interruption of the vein draining blood from Sg5 into middle hepatic vein. 
Caudally, isolation of portal triad vessels for right hemiliver and consecutive interruption of 
blood supply for Sg5,6. Their ischaemia results in demarcation of their borderline to Sg7,8 
and iii) parenchymal transection along this borderline. Caudally, right hepatic vein anterior 
branch draining blood from Sg5,6 is interrupted and portal triad vessels for Sg7,8 are 
obligatorily preserved. 
Bisegmentectomy 7,8 is possible only in the presence of inferior right hepatic vein draining 
blood from Sg6. Bisegmentectomy 7,8 passes through four stages: i) mobilization of right 
hemiliver through interruption of lig. triangulare dextrum and lig. coronarium hepatis dextrum. 
Right hemiliver is luxated to the left and the retrohepatic portion of vena cava inferior is 
liberated. Identification of inferior right hepatic vein enables technical performance of 
bisegmentectomy 7,8, ii) definition of resection borderlines. Hilar clamping the vessels for 
right hemiliver results in ischaemic demarcation line at the borderline between Sg5,8 and 
Sg4. Parenchymal transection along this line between Sg8 and Sg4. ‘Hanging’-maneuver 
facilitates hepatic resection. Resection borderline between proximal (Sg7,8) and transversal 
(Sg5,6) segments is defined by means of intraoperative echography, iii) parenchymal 
transection along resection borderlines with Sg7,8 devascularization starting at the 
borderline between Sg6 and Sg7. Initially, right hepatic vein anterior branch is identified 
and interrupted. Then, in a transversal plane, portal triad vessels for Sg7,8 are reached and 
interrupted and iv) parenchymal transection in a sagittal plane at the borderline between 
Sg8 and Sg4. Caudally, the vein draining blood from Sg8 into middle hepatic vein is ligated. 
Finally, right hepatic vein branch is interrupted. 
Bisegmentectomy 4a,8 passes through four stages: i) mobilization of right hemiliver through 
interruption of lig. triangulare dextrum and lig. coronarium hepatis dextrum. Right hemiliver is 
luxated to the left and then right hepatic vein branch is extrahepatically mobilized, ii) 
definition of resection borderlines. Hilar dissection enables the isolation of the artery and 
portal vein for Sg5,8. Their clamping visualizes the borderline between Sg8 and Sg6, on the 
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one hand, and between left and right hemiliver, on the other hand. Transversal resection 
borderline between Sg8 and Sg5 is established by means of intraoperative echography while 
the left borderline passes along lig. falciforme hepatis, iii) parenchymal transection along Rex-
Cantlie line and consecutive interruption of the veins draining blood from Sg5,8 into middle 
hepatic vein and portal triad vessels for Sg8. Sg8 devascularization results in ischaemic 
demarcation line at the borderline to Sg5 and iv) parenchymal transection along this line 
continuing in a sagittal plane between Sg7 and Sg8 and reaching cranially up to the 
borderline between the right and the middle hepatic vein. Next follows parenchymal 
transection along lig. falciforme hepatis in order to liberate Sg4a ending, cranially, at the 
borderline between the left and the middle hepatic vein. Finally, both Sg8 and Sg4a are 
entirely mobilized around middle hepatic vein which is interrupted at its basis. 
5.3.3 Multisegmentectomies 
i. Stages of the following multisegmentectomies - mesohepatectomy with preservation of 
Sg1; mesohepatectomy together with Sg1; resection of Sg4b,5,6 and Spiegel’s lobe; 
resection of Sg3,4b,5; resection of Sg3,5-7; resection of parts of Sg3,4b,5,6,8; resection of 
Sg4b,6,7, and resection of Sg6-8:  
Mesohepatectomy (Sg4,5,8) consists in removal of three segments both of which (Sg5 and 
Sg8) belong anatomically to the right hemiliver while Sg4 belongs to the left hemiliver. This 
operation is applied in centrally located liver metastases enabling R0 (Fig. 17). 
Mesohepatectomy with preservation of Sg1 passes through six stages: i) mobilization of left 
and right hemiliver as double ‘hanging’-maneuver lifting on a holder of the right and left 
hepatic veins facilitates hepatic resection, ii) definition of right resection borderline by 
consecutive interruption of the artery and portal vein for Sg5,8 (Fig. 18). Parenchymal 
transection visualizes right resection borderline between Sg5,8 and Sg6,7, iii) interruption of 
the artery and ascendant portal veins for Sg4 through extrahepatic access. To the left, 
resection line passes along lig. falciforme hepatis. Sg4,5,8 devascularization enables 
mesohepatectomy at minimal blood loss, iv) parenchymal transection along lig. falciforme  
 
 
Fig. 17. CT image of liver metastasis in Sg4,5,8 
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hepatis ending at the borderline between the middle and the left hepatic vein. Consecutive 
interruption of descendent portal veins, the bile duct for Sg4 and the vein draining blood from 
lobus quadratus in left hepatic vein, v) parenchymal transection at the borderline between Sg5,8 
and Sg6,7 and consecutive interruption of the vein draining blood from Sg5 into right hepatic 
vein anterior branch and portal triad vessels for Sg5,8. To the right, parenchymal transection 
ends at the borderline between the right and the middle hepatic vein and vi) interruption of 
middle hepatic vein around which these already liberated Sg5,8 and Sg4 are located (Fig. 19). 
Residual liver volume after removal of Sg4,5,8 is shown on Fig. 20. 
 
 
Fig. 18. Liver resection volume in mesohepatectomy (Sg4,5,8) 
 
Fig. 19. The site for interruption of the middle hepatic vein is indicated by a circle. MHV - 
middle hepatic vein; RHV - right hepatic vein 
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Fig. 20. Residual liver volume after mesohepatectomy (Sg4,5,8) 
Mesohepatectomy with segmentectomy 1 is indicated in tumours of central location and 
passes through seven stages already described in detail in single segmentectomy chapters: i) 
mobilization of left and right hemiliver by means of double ‘hanging’-maneuver, ii) Sg5,8 
devascularization through extrahepatic access, iii) Sg4 devascularization through 
extrahepatic access for the artery and ascendant portal veins, iv) Sg1 devascularization with 
liberation of the retrohepatic part of vena cava inferior, v) parenchymal transection along lig. 
falciforme hepatis ending at the borderline between the middle and the left hepatic vein. 
Caudally, identification and interruption of descendent portal veins for Sg4 enabling the 
opening of Rex recessus. Interruption of bile ducts for Sg4 located in Rex recessus, vi) 
parenchymal transection at the borderline between Sg5,8 and Sg6,7 and vii) middle hepatic 
vein interruption at the end of parenchymal transection and obligatory intraoperative 
cholangiography after resection of Sg1,4,5,8 for control of bile drainage from the remnant 
liver parenchyma. 
Resection of Sg4b,5,6 and Spiegel’s lobe combines the already described stages in resections 
of Sg1,4-6. Portal triad vessels for Sg7,8 are obligatorily preserved. 
Resection of Sg3,4b,5 combines the already described stages in resections of Sg3,4b,5. Portal 
triad vessels for Sg6,8 are obligatorily preserved. 
Resection of Sg3,5-7 combines the already described stages in resections of Sg3,5-7. Portal 
triad vessels for Sg8 are obligatorily preserved. 
Resection of parts of Sg3,4b,5,6,8 combines the already described stages in resections of 
Sg3,4b,5,6,8. 
Resection of Sg4b,6,7 combines the already described stages in resections of Sg4b,6,7.  
Resection of Sg6-8 combines the already described stages in resections of Sg6-8. Portal triad 
vessels for Sg5 are obligatorily preserved. 
ii. Stages of the following hemihepatectomies - left hemihepatectomy (Sg2-4), and right 
hemihepatectomy (Sg5-8): 
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Left hemihepatectomy passes through three stages: i) mobilization of left hemiliver through 
consecutive interruption of lig. triangulare dextrum and lig. coronarium hepatis sinistrum. 
Devascularization of left hemiliver with ligation of left hepatic artery and portal vein left 
branch. If possible, left hepatic duct is liberated without its interruption. Extrahepatically, 
the trunk of the left and the middle hepatic vein is mobilized enabling the application of 
‘hanging’-maneuver, ii) parenchymal transection along the ischaemic demarcation line 
between left and right hemiliver. Resection borderline is defined after injection of 10 mL of 
methylene blue through portal vein left branch and iii) finally, consecutive interruption of 
left hepatic duct and left hepatic vein-middle hepatic vein branch. Middle hepatic vein is 
preserved, if indicated. 
Right hemihepatectomy passes through three stages: i) mobilization of right hemiliver 
through consecutive interruption of lig. triangulare dextrum and lig. coronarium hepatis 
dextrum, ii) interruption of the right hepatic and the portal vein right branch. If possible, 
right hepatic duct is liberated without its interruption. Right hepatic vein mobilization by 
means of ‘hanging’-maneuver facilitates liver resection. Right hemiliver devascularization 
results in ischaemic demarcation line at the borderline to left hemiliver, and iii) 
parenchymal transection at the borderline between left and right hemiliver and consecutive 
ligation of the veins draining blood from Sg5,8 into middle hepatic vein. Finally, 
interruption of right hepatic duct and right hepatic vein as well as of middle hepatic vein, if 
indicated. 
iii. Stages of the following trisectionectomies - left trisectionectomy (Sg2-5,8), and right 
trisectionectomy (Sg4-8): 
Left trisectionectomy is used in tumours affecting left hemiliver and Sg5,8. No preoperative 
embolization of portal vein left branch is needed as preserved Sg7 and Sg 6 amount to 30-
35% of standard liver volume. Left trisectionectomy passes through five stages: i) 
mobilization of left hemiliver through consecutive interruption of lig. triangulare sinistrum 
and lig. coronarium hepatis sinistrum. ‘Hanging’-maneuver application facilitates resection, ii) 
devascularization of left hemiliver with ligation of left hepatic artery and portal vein left 
branch, iii) Sg5,8 devascularization through extrahepatic access . Sg5,8 ischaemia causes 
demarcation line at the borderline to Sg6,7 along which parenchymal transection is 
performed, iv) consecutive interruption of the vein draining blood from Sg5 into middle 
hepatic vein and intraparenchymal portal triad vessels for Sg5,8. Parenchymal transection 
ends at the borderline between the right and the middle hepatic vein. Right hepatic vein is 
lifted on a rubber holder in order to prevent its injury and v) finally, the trunk of the middle 
and the left hepatic vein is interrupted. Portal triad vessels for Sg6,7 are obligatorily 
preserved. 
Right trisectionectomy is used in tumours affecting right hemiliver and Sg4. In most cases, 
preoperative embolization of portal vein right branch is needed in order to achieve 
hypertrophy of the left hemiliver and, in particular, of Sg2 and Sg3. Right trisectionectomy 
passes through five stages: i) mobilization of right hemiliver through consecutive 
interruption of lig. triangulare dextrum and lig. coronarium hepatis dextrum and short 
retrohepatic veins; ii) devascularization of right hemiliver with ligation of the right and 
middle hepatic arteries and the right branch of the portal vein (Fig. 21); iii) devascularization 
of lobus quadratus by means of interruption of the artery and ascendent portal veins for Sg4 
through extrahepatic access (Fig. 22).  
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Fig. 21. Right and middle hepatic arteries as well as portal vein right branch are interrupted. 
LHA – left hepatic artery; RHA - right hepatic artery 
 
 
Fig. 22. Sites for interruption of the veins for Sg4 through a combined access.  
The interruption of the right hepatic duct is presented on Fig. 23. A preserved left hepatic 
vein (single ‘hanging’-maneuver) is indicated on Fig. 24, iv) parenchymal transection along 
lig. falciforme hepatis and consecutive interruption of descendent portal veins for Sg 4. 
Entering Rex recessus with interruption of the bile ducts for Sg4 (Fig. 25), and v) cranial 
ligation of the middle and the right hepatic veins (Fig. 26).  
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Fig. 23. Interruption of right hepatic duct 
 
 
 
Fig. 24. Preservation of the left hepatic vein through a single ‘hanging’-maneuver 
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Fig. 25. Entering Rex recessus with interruption of the bile ducts for Sg4 
In case of damaged blood supply to common hepatic duct, these vessels should be removed 
with subsequent biliodigestive anastomosis between left hepatic duct and intestinal loop 
isolated after Roux. Fig. 27 shows residual liver volume following right trisectionectomy. 
 
 
Fig. 26. Interruption of the middle and the right hepatic veins. MHV – middle hepatic vein; 
RHV – right hepatic vein, VCI - vena cava inferior 
www.intechopen.com
 Colorectal Cancer – From Prevention to Patient Care 
 
432 
 
Fig. 27. Residual liver volume after right trisectionectomy 
6. Results 
The results concerning various clinical and laboratory characteristics of the patients having 
undergone different types of segmentectomies and major liver resections were 
comparatively demonstrated. The main attention was paid to the following basic 
parameters: number, diameter, and localization of colorectal liver metastases; postoperative 
mortality rate; complications; blood loss and required blood transfusions; operative 
duration; length of hospital stay; resection margins, one-, two and three-year disease-free 
and overall survival rates.  
Some of them are shown in the present paper. 
Postoperative complications following monosegmentectomies and bisegmentectomies, on 
the one hand, and multisegmentectomies, on the other hand, are comparatively presented 
on Table 5. 
It is evident that, as a whole, liver damage caused by the surgical intervention itself occurs 
statistically significantly more commonly in the patients who have undergone 
multisegmentectomies. 
Some surgical characteristics of monosegmentectomies and bisegmentectomies, on the one 
hand, and multisegmentectomies, on the other hand, are comparatively presented on Table 6. 
Obviously, several surgical patterns of undoubted medical and socio-economic importance 
such as total blood loss, necessity of blood transfusions and of application of Pringle-
maneuver are statistically significantly more unfavourable in the patients who have 
undergone multisegmentectomies.  
Besides, these patients require statistically significantly more often the performance of 
repeated surgical interventions on the occasion of colorectal liver metastases than those who 
have undergone mono- or bisegmentectomies. 
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Complications 
Number of removed segments 
p 
one or two ≥ three 
number and percentage of patients with complications 
37 (34%) 11 (10%) 26 (24%) 0.092 
surgical liver damage 8 (7.4%) 19 (18%) 0.009 
hemorrhage 2 (1.8%) 4 (3.7%)  
liver failure 2 (1.8%) 14 (13%)  
bilirrhagia from an opened bile duct 3 (2.7%) 9 (8.3%)  
extrahepatic biliary tree necrosis - 1 (1%)  
purulent perihepatic collection 2 (1.8%) 4 (3.7%)  
cholangitis 2 (1.8%) 3 (2.7%)  
mechanical jaundice - 2 (1.8%)  
peritonitis - 2 (1.8%)  
ascites 2 (1.8%) 14 (13%)  
respiratory tract damage 6 (5.5%) 11 (10%) 0.034 
pneumothorax 2 (1.8%) 2 (1.8%)  
pulmonary thromboembolism - 1 (1%)  
respiratory failure 2 (1.8%) 9 (8.3%)  
pleural effusion > 200 mL 4 (3.7%) 9 (8.3%)  
other complications 3 (2.7%) 8 (7.4%) 0.060 
drug-resistant renal failure 2 (1.8%) 7 (6.5%)  
drug-resistant heart failure 2 (1.8%) 7 (6.5%)  
sepsis 2 (1.8%) 8 (7.4%)  
deep vein thrombosis 1 (1%) 1 (1%)  
complications of general nature 8 (7.4%) 15 (13.8%) 0.014 
operative wound suppuration 8 (7.4%) 12 (11%)  
operative wound dehiscence 3 (2.7%) 6 (5.5%)  
postoperative herniation 8 (7.4%) 15 (13.8%)  
Table 5. Complications after liver resections 
 
Parameters 
Number of removed segments 
p 
one or two ≥ three 
positive resection area 2 (1.8%) 4 (3.7%) 0.299 
duration of surgery (min) 224±19 211±21 0.368 
total blood loss (mL) 480±52 682±48 < 0.001 
necessity of haemotransfusion (patients) 16 (14.8%) 45 (41.6%) < 0.001 
necessity of Pringle-maneuver (patients) 20 (18.5%) 52 (48.1%) < 0.001 
stay in reanimation ward (days) 2±1.2 1.5±0.5 0.459 
hospital stay (days) 14.7±1.4 13.5±1.6 0.269 
repeated operation 2 (1.8%) 9 (8.3%) < 0.001 
Table 6. Surgical patterns of patients with liver resections 
Three-year patients’ survival assessed by means of the variables of 22 prognostic criteria is 
presented on Table 7. 
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Variables of prognostic criteria n % p 
Males 
females 
age < 65 years 
age ≥ 65 years 
T2-T3 category 
T4 category 
G1-G2 tumour differentiation  
G3 tumour differentiation 
negative lymph nodes during colorectal cancer surgery  
positive lymph nodes during colorectal cancer surgery  
colonic primary tumour 
rectal primary tumour 
CEA ≤ 200 ng/mL  
CEA > 200 ng/mL 
synchronous metastases 
metachronous metastases 
after < 12 months  
after ≥ 12 months  
diameter < 50 mm 
diameter ≥ 50 mm  
≤ 3 metastases  
> 3 metastases  
unilobar metastases 
bilobar metastases 
positive resection areas  
negative resection areas  
positive lymph nodes in lig. hepatogastroduodenale 
negative lymph nodes in lig. hepatogastroduodenale 
resection distance ≥ 10 mm  
resection distance of 5-10 mm 
resection distance ≤ 5 mm 
monosegmentectomy and bisegmentectomy 
multisegmentectomy 
blood loss > 500 mL  
blood loss ≤ 500 mL 
application of Pringle-maneuver  
no application of Pringle-maneuver  
postoperative complications 
no postoperative complications 
0-2 factors of MSKCC-CRS  
3-5 factors of MSKCC-CRS  
extrahepatic dissemination 
no extrahepatic dissemination 
neoadjuvant chemotherapy 
no neoadjuvant chemotherapy 
32
21 
41 
12 
32 
21 
35 
18 
33 
20 
38 
15 
42 
11 
13 
40 
35 
18 
42 
11 
48 
5 
41 
12 
- 
53 
1 
52 
42 
5 
6 
29 
24 
29 
24 
34 
19 
29 
24 
41 
12 
2 
51 
13 
40 
47 
53 
51 
43 
52 
46 
50 
47 
53 
43 
51 
45 
71 
26 
59 
50 
51 
46 
49 
50 
55 
30 
48 
52 
- 
52 
6 
60 
52 
56 
50 
66 
41 
48 
51 
47 
52 
46 
53 
64 
27 
25 
54 
52 
48 
 
0.582 
 
0.743 
0.944 
0.934 
 
0.677 
 
0.877 
 
0.983 
 
< 0.001 
 
0.834 
 
0.221 
 
0.712 
 
< 0.001 
 
0.069 
 
< 0.001 
 
< 0.001 
0.700 
0.790 
 
 
< 0.001 
 
0.644 
 
0.736 
 
0.743 
 
< 0.001 
 
< 0.001 
 
0.628 
Table 7. Prognostic criteria for three-year survival 
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We identify a small number of prognostic criteria which could be considered statistically 
significant in the patients with colorectal liver metastases. Here belong the increased levels 
of CEA, the higher number of colorectal liver metastases (more than three), the negative 
resection areas, the presence of negative lymph nodes in lig. hepatogastroduodenale, the 
implementation of multisegmentectomy as a less sparing surgical intervention, the presence 
of at least 3 factors of MSKCC-CRS and the absence of extrahepatic dissemination of the 
pathological process.  
Thus our investigations should be enlarged in future in order to more comprehensively 
explain the dynamic interactions between the single risk factors for the relatively poor 
prognosis of this contingent of patients. 
7. Discussion  
Our own results demonstrate the substantial advantages of segmental resection for 
colorectal liver metastases over major liver resection (Kobakov & Kostov, 2006; Kostov & 
Kobakov, 2006b; Kostov & Kobakov, 2009). They are the following: conservation of a 
sufficient liver volume, achievement of lower perioperative morbidity and mortality rates as 
well as warranting the similar disease-free and overall survival rates. Liver conservation is 
essential in normal and damaged liver. It reduces the risk of postoperative liver 
insufficiency from a small liver remnant and in the patients at advanced age or with 
cirrhosis.  
The following prognostic factors exert a statistically significant effect on short- and long-
term survival rates after liver resections for colorectal liver metastases: CEA level, presence 
of metastatic nodes along lig. hepatoduodenale, number of metastases, extension of liver 
resection, resection volume, number of prognostic factors according to MSKCC, and 
extrahepatic dissemination of primary colorectal cancer.  
The following therapeutic strategy should be recommended: i) liver resection for resectable 
colorectal metastases (at stages IVA and IVB); ii) neoadjuvant chemotherapy for primarily 
non-resectable colorectal metastases (at stage IVC) when downstaging is feasible to allow 
radical surgery, and iii) only chemotherapy for colorectal metastases in stage IVD patients. 
Recent literature data convincingly indicate the uninterrupted progress in the 
interdisciplinary field of oncologic liver surgery. Along with original investigations, a lot of 
review papers, meta-analyses, multicentre reports and randomized controlled trials are 
currently published by authors from all over the world. 
In this respect, multimodal therapy deserves a special attention. It increases the number of 
resections and improves long-term survival rate (currently more than 40% at 5 years) 
(Neumann et al., 2010). Advances in staging, surgical technique, perioperative care and 
systemic chemotherapy contribute to improvement in oncologic outcomes of stage IV 
colorectal cancer patients (Abdalla, 2011). The limits of resection expand to include cases 
with more, larger and bilateral colorectal liver metastases as 5-year overall survival exceeds 
50% following resection. Tailored, patient-centered treatment includes a variety of liver 
resections, liver volumetry, and portal vein embolization for preoperative enhancement of 
the volume and function of the planned future remnant liver (Abdalla, 2011).  
Multimodality approach of laparoscopic liver resection is feasible and safe in selected 
patients. It is associated with a low complications rate (Isoniemi et al., 2011, Lai et al., 2011). 
Intraoperative ablation extends the limits of hepatectomy in the patients not amenable to 
complete resection (Brown et al., 2011; Govindarajan et al., 2011; Hammill et al., 2011; 
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Hompes et al., 2011). Portal vein embolization, radiofrequency ablation, two-stage 
hepatectomy, conversion therapy and reverse treatment strategy along with hepatectomy 
are used in the presence of extrahepatic disease (Coimbra et al. 2011; Narita et al., 2011, Tsim 
et al., 2011). Resection of advanced colorectal liver metastases after a second-line 
chemotherapy regimen is safe and promising in certain cases. The addition of neoadjuvant 
chemotherapy should, however, be cost-effective. 
Positron emission tomography/computed tomography have a higher accuracy for detection 
of extra-hepatic and colorectal liver metastases than computed tomography alone (Patel et 
al., 2011). In patients treated with neoadjuvant chemotherapy, magnetic resonance imaging 
measurements of steatosis show the highest correlation coefficient and the best diagnostic 
accuracy, as compared to computed tomography ones (Marsman et al., 2011). Intraoperative 
ultrasound and preoperative imaging significantly increase the diagnostic accuracy of 
patients undergoing liver resection for colorectal liver metastases (Lordan et al., 2011). 
Metachronous resections have a better outcome than synchronous. Iterative resection is very 
encouraging and justifies an aggressive surgical approach (Tonelli et al., 2010). 
Simultaneous resection is safe and efficient in the treatment of patients with synchronous 
colorectal liver metastases while avoiding a second major operation (Chen et al., 2011). In 
patients with bilobar synchronous colorectal liver metastases who are candidates for two-
stage hepatectomy, combined resection of the primary tumour and first-stage he patectomy 
reduces the number of procedures, optimizes chemotherapy administration and may 
improve outcome (Karoui et al., 2010). The two-stage strategy for colorectal liver metastases 
can be performed with acceptable morbidity and mortality. The second stage is not feasible 
in 20-25% of patients. Patients completing the two-stage approach may have long-term 
survival comparable to those treated with a planned single-stage hepatectomy (Tsai et al., 
2010). Concomitant extrahepatic disease in a patient with colorectal liver metastases should 
not be a contraindication to their resection. 
As there is no significant difference in morbidity, mortality, recurrence rate, or survival in 
anatomical and nonanatomical liver resections, the latter can be used as a save procedure to 
preserve liver parenchyma (Lalmahomed et al., 2011). The Pringle maneuver does not seem 
to affect the survival of patients with liver metastases (Ferrero et al., 2010). Ultrasound-
guided finger compression of sectional portal pedicle feeding the right posterior section is a 
feasible, safe, and effective method for performing anatomical right posterior sectionectomy 
(Torzilli et al., 2011). 
Prognostic factors and score systems occupy an important place in oncologic liver surgery 
(de Haas et al., 2011; Peng et al., 2011; Pulitanò et al., 2011). Although twelve prognostic 
scoring systems have been identified from 1996 to 2009, there is no 'ideal' system for the 
clinical management of patients with colorectal liver metastases (Gomez et al., 2010). A 
predicted positive surgical margin (R1 resection) is not any absolute contraindication to 
surgery for aggressive or advanced colorectal liver metastases (Tanaka et al., 2011). Liver 
resection has superior long-term survival which is, however, significantly reduced by the 
occurrence of post-surgical complications (Schepers et al., 2010). Superior overall health-
related quality of life merits an aggressive surgical approach and intensive follow-up to 
detect recurrence early (Wiering et al., 2011). 
8. Conclusion  
Based on our own results and reliable scientific evidence available worldwide up-to-date, it 
can be concluded that the patient presenting with colorectal liver metastases deserves a 
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timely and individualized diagnostic and complex therapeutic approach by an 
interdisciplinary physician’s team. Medical staff’s behaviour should be maximally sparing, 
when possible.  
New advances in image diagnostic modalities such as positron emission 
tomography/computer-aided tomography, steadily improved surgical and microsurgical 
techniques such as laparoscopic resections along with emerging opportunities for cost-
effective chemotherapy and multimodal management promise better perspectives in this 
field of permanently rising social significance. 
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